Citations

Showing 10 of 108094 citations.

Continual near-infrared spectroscopy monitoring in the injured lower limb and acute compartment syndrome
Shuler, Michael S. , Roskosky, Mellisa , Kinsey, Tracy L. , Glaser, Dale , Reisman, W. Michael , Ogburn, C., Yeoman, C M, Wanderman, Nathan , Freedman, Brett A.

Mayo Clinic

The Bone & Joint Journal | June 7, 2018 | Volume: 100-B | Issue: 6 | Pages: 787-797

10.1302/0301-620x.100b6.bjj-2017-0736.r3 | PMID 29855235 Get It

AimsThe aim of this study was to evaluate near-infrared spectroscopy (NIRS) as a continuous, non-invasive monitor for acute compartment syndrome (ACS).Patients and MethodsNIRS sensors were placed on 86 patients with, and 23 without (controls), severe leg injury. NIRS values were recorded for up to 48 hours. Longitudinal data were analyzed using summary and graphical methods, bivariate comparisons, and multivariable multilevel modelling.ResultsMean NIRS values in the anterior, lateral, superficial posterior, and deep posterior compartments were between 72% and 78% in injured legs, between 69% and 72% in uninjured legs, and between 71% and 73% in bilaterally uninjured legs. In patients without ACS, the values were typically > 3% higher in injured compartments. All seven limbs with ACS had at least one compartment where NIRS values were 3% or more below a reference uninjured control compartment. Missing data were encountered in many instances.ConclusionNIRS oximetry might be used to aid the assessment and management of patients with ACS. Sustained hyperaemia is consistent with the absence of ACS in injured legs. Loss of the hyperaemic differential warrants heightened surveillance. NIRS values in at least one injured compartment(s) were > 3% below the uninjured contralateral compartment(s) in all seven patients with ACS. Additional interventional studies are required to validate the use of NIRS for ACS monitoring. Cite this article: Bone Joint J 2018;100-B:787–97.
De Novo DNM1L Variant in a Teenager With Progressive Paroxysmal Dystonia and Lethal Super-refractory Myoclonic Status Epilepticus
Ryan, Conor S. , Fine, Anthony L. , Cohen, Alexander L. , Schiltz, Brenda , Renaud, Deborah L. , Patterson, Marc C. , Boczek, Nicole J. , Babovic‐Vuksanovic, Dusica , Payne, Eric T. , Schiltz, Brenda M, Wirrell, Elaine C., Babovic-Vuksanovic, Dusica, Fine, Anthony , Cohen, Alexander , Wirrell, Elaine , Liu, Raymond, Chan, David C. M. , Patterson, Marc

Mayo Clinic

Journal of Child Neurology | June 7, 2018 | Volume: 33 | Issue: 10 | Pages: 651-658

10.1177/0883073818778203 | PMID 29877124 Get It

Background: The dynamin 1-like gene ( DNM1L) encodes a GTPase that mediates mitochondrial and peroxisomal fission and fusion. We report a new clinical presentation associated with a DNM1L pathogenic variant and review the literature. Results: A 13-year-old boy with mild developmental delays and paroxysmal dystonia presented acutely with multifocal myoclonic super-refractory status epilepticus. Despite sustained and aggressive treatment, seizures persisted and care was ultimately withdrawn in the context of extensive global cortical atrophy. Rapid trio-whole exome sequencing revealed a de novo heterozygous c.1207C>T (p.R403C) pathogenic variant in DNM1L. Immunofluorescence staining of fibroblast mitochondria revealed abnormally elongated and tubular morphology. Conclusions: This case highlights the diagnostic importance of rapid whole exome sequencing within a critical care setting and reveals the expanding phenotypic spectrum associated with DNM1L variants. This now includes progressive paroxysmal dystonia and adolescent-onset super-refractory myoclonic status epilepticus contributing to strikingly rapid and progressive cortical atrophy and death.
Peribiliary cysts: a systematic review and proposal of a classification framework
Bazerbachi, Fateh , Haffar, Samir , Mounajjed, Taofic, Takahashi, Naoki , Murad, M. Hassan , Mounajjed, Taofic M, Murad, Mohammad Hassan, Abu Dayyeh, Barham K, Bazerbachi, F , Murad, M Hassan , Sugihara, Takaaki , Dayyeh, Barham K. Abu , Takahashi, Naoki

Mayo Clinic

BMJ Open Gastroenterology | June 7, 2018 | Volume: 5 | Issue: 1 | Pages: e000204

10.1136/bmjgast-2018-000204 | PMID 29915665 Get It

Objective Peribiliary cysts are usually benign, although severe complications and mortality may occur, and they may be confounded with other diseases. No classification delineating their different characteristics exists. Design We performed a systematic review of the frequency and clinical manifestations of peribiliary cysts. Two reviewers identified studies after searching multiple databases on 2 August 2017. Results These cysts were prevalent in cirrhosis (9%). A total of 135 patients were reported in 72 papers with sufficient clinical data (10 countries, 65% from Japan, median age 63 years (range: 4–88), and 80% were males). Symptoms were present in 70%. Misdiagnosis occurred in 40%, and 33% underwent therapeutic misadventures. Cysts were solitary in 10%. Obstructive features and cholangitis were observed in 36% and 12.5%, respectively. Cysts progression was observed in 37.5% over a median of 18 months. Mortality was 24%, mostly due to cirrhosis. A classification framework is proposed, wherein type I includes hepatic, type II extrahepatic and type III mixed hepatic and extrahepatic cysts, each having distinct features. Specifically, type II was more frequent in females, solitary, without cirrhosis, presenting with obstructive jaundice, more difficult to diagnose and required more surgical interventions (all p<0.05). Conclusion Although rarely studied in the literature, peribiliary cysts were frequent in studies designed to evaluate their prevalence, and were mostly asymptomatic. Inaccurate diagnosis, therapeutic misadventures, cysts progression and cysts-related complications are frequent. In a novel classification framework based on location, extrahepatic peribiliary cysts have distinct characteristics and require a special approach for diagnosis and management.
Comparative Usability Study of a Newly Created Patient-Centered Tool and Medicare.gov Plan Finder to Help Medicare Beneficiaries Choose Prescription Drug Plans
Fattahi, Sayeh , Meehan, Amy , Bundorf, M. Kate , Pun, Ting, Tai-Seale, Ming, Stults, Cheryl D. , Chan, Albert Solomon , Tai‐Seale, Ming

Mayo Clinic

Journal of Patient Experience | June 7, 2018 | Volume: 6 | Issue: 1 | Pages: 81-86

10.1177/2374373518778343 | PMID 31236456 Get It

Introduction: In response to reported difficulties in selecting a Medicare Part D prescription drug plan, we designed a patient-centered online Part D plan selection tool (CHOICE1.0) to simplify the selection process and to provide personalized, expert recommendations. Methods: This ethnographic comparative usability study observed 44 patients using the first version of the tool during Medicare 2016 Open Enrollment. Participants were observed as they chose their drug plan using Medicare.gov and 1 of 3 versions of CHOICE1.0 that varied in amount of expert guidance. Descriptive statistics were used to analyze exit survey data. The observations were video-recorded, and field notes were analyzed thematically. Results: Participants were significantly more satisfied with CHOICE1.0 for choosing a plan, understanding information, and ease of use compared to Medicare.gov . Those using expert versions of CHOICE1.0 were more likely to indicate their intention to switch plans than those using Medicare.gov , though they wanted to know the source and content. Conclusion: The more patient-centered prescription drug choice tool improved user experience and enabled users to choose plans more consistent with expert recommendations.
Isolation and Characterization of Multipotent Turkey Tendon-Derived Stem Cells
Liu, Qian , Zhu, Yaxi , Amadio, Peter C. , Moran, Steven L. , Gingery, Anne , Zhao, Chunfeng , Liu, Qian , Gingery, Anne

Mayo Clinic

Stem Cells International | June 6, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-10

10.1155/2018/3697971 | PMID 29977306 Get It

Tendon injuries are among the most common and severe hand injuries with a high demand for functional recovery. Stem cells have been identified and isolated from different species and a variety of tissues for the sake of regenerative medicine. Recently, turkey has been suggested as a potential new large animal model for flexor tendon-related research. However, turkey tissue-specific stem cells have not been investigated. Here, we presented the isolation and verification of tendon-derived stem cells (TDSCs) from 6- to 8-month-old heritage-breed turkey. TDSCs were isolated from turkey flexor tendon by plating nucleated cells at the determined optimal density. Approximately 4% of the nucleated cells demonstrated clonogenicity, high proliferation rate, and trilineage differentiation potential after induction culturing. These cells expressed surface antigens CD90, CD105, and CD44, but did not express CD45. There was a high level of gene expression of tenogenic markers in TDSCs, including mohawk, collagen type I, tenascin C, and elastin. Turkey TDSCs also expressed transcription factorsPouV,Nanog, andSox2, which are critically involved in the regulation of stemness. The successful isolation of tendon-derived stem cells from turkey was beneficial for future studies in tendon tissue engineering and would help in the development of new treatment for tendon diseases using this novel animal model.
Premature Physiologic Aging as a Paradigm for Understanding Increased Risk of Adverse Health Across the Lifespan of Survivors of Childhood Cancer
Ness, Kirsten K. , Kirkland, James L. , Wang, Zhaoming , Kundu, Mondira , McCastlain, Kelly , Li-Harms, Xiujie , Zhang, Jinghui , Tchkonia, Tamar , Pluijm, Saskia Martine Francesca, Armstrong, Gregory T. , Gramatges, Maria Monica, Wang, Zhaoming , Tchkonia, T , Gramatges, Maria Monica , Pluijm, Saskia M.F. , Ness, Kirsten K

Mayo Clinic

Journal of Clinical Oncology | June 6, 2018 | Volume: 36 | Issue: 21 | Pages: 2206-2215

10.1200/jco.2017.76.7467 | PMID 29874132 Get It

The improvement in survival of childhood cancer observed across the past 50 years has resulted in a growing acknowledgment that simply extending the lifespan of survivors is not enough. It is incumbent on both the cancer research and the clinical care communities to also improve the health span of survivors. It is well established that aging adult survivors of childhood cancer are at increased risk of chronic health conditions, relative to the general population. However, as the first generation of survivors age into their 50s and 60s, it has become increasingly evident that this population is also at risk of early onset of physiologic aging. Geriatric measures have uncovered evidence of reduced strength and speed and increased fatigue, all components of frailty, among survivors with a median age of 33 years, which is similar to adults older than 65 years of age in the general population. Furthermore, frailty in survivors independently increased the risk of morbidity and mortality. Although there has been a paucity of research investigating the underlying biologic mechanisms for advanced physiologic age in survivors, results from geriatric populations suggest five biologically plausible mechanisms that may be potentiated by exposure to cancer therapies: increased cellular senescence, reduced telomere length, epigenetic modifications, somatic mutations, and mitochondrial DNA infidelity. There is now a critical need for research to elucidate the biologic mechanisms of premature aging in survivors of childhood cancer. This research could pave the way for new frontiers in the prevention of these life-changing outcomes.
Progress in Primary Biliary Cholangitis
Carey, Elizabeth J.

Mayo Clinic

New England Journal of Medicine | June 6, 2018 | Volume: 378 | Issue: 23 | Pages: 2234-2235

10.1056/nejme1804945 | PMID 29874531 Get It

Neurocritical Care: The Continued Evolution
McLaughlin, Diane , McLaughlin, Diane C

Mayo Clinic

AACN Advanced Critical Care | June 6, 2018 | Volume: 29 | Issue: 2 | Pages: 150-151

10.4037/aacnacc2018750 | PMID 29875111 Get It

Multimodal Neuromonitoring in Neurocritical Care
Peacock, Sarah , Tomlinson, Amanda, Peacock, Sarah H, Tomlinson, Amanda D

Mayo Clinic

AACN Advanced Critical Care | June 6, 2018 | Volume: 29 | Issue: 2 | Pages: 183-194

10.4037/aacnacc2018632 | PMID 29875115 Get It

Neuromonitoring is important for patients with acute brain injury. The bedside neurologic examination is standard for neurologic monitoring; however, a clinical examination may not reliably detect subtle changes in intracranial physiology. Changes found during neurologic examinations are often late signs. The assessment of multiple physiological variables in real time can provide new clinical insights into treatment decisions. No single monitoring modality is ideal for all patients. Simultaneous assessment of cerebral hemodynamics, oxygenation, and metabolism, such as in multimodal monitoring, allows an innovative approach to individualized patient care.
Borrowing Ribs to Treat the Elbow: What’s the Rub?
Camp, Christopher L. , Camp, Christopher L.

Mayo Clinic

Journal of Bone and Joint Surgery | June 6, 2018 | Volume: 100 | Issue: 11 | Pages: e80

10.2106/jbjs.18.00097 | PMID 29870454 Get It